期刊文献+

依达拉奉治疗血管源性帕金森综合征的疗效评价 被引量:10

下载PDF
导出
摘要 目的探讨依达拉奉治疗血管源性帕金森综合征的临床效果。方法分别采用依达拉奉治疗法(依达拉奉治疗+美多巴、克瑞帕、阿司匹林治疗)和常规治疗法(美多巴、阿司匹林治疗)对血管源性帕金森综合征患者进行治疗,比较其治疗效果。结果 76例血管源性帕金森综合征患者分别经常规治疗法与依达拉奉治疗后对比可见,依达拉奉治疗可减缓血管源性帕金森综合征患者精神、行为和情绪症状,组间比较P<0.05,具有统计学意义。但患者日常生活活动评分及运动功能评分,两组患者无明显差异,P>0.05。结论针对血管源性帕金森综合征患者采用传统治疗结合依达拉奉治疗,可明显减缓患者精神、行为和情绪症状,提高患者的治疗有效率。
出处 《中国医药指南》 2013年第14期587-588,共2页 Guide of China Medicine
  • 相关文献

参考文献4

  • 1Winikates J,Jankovic J.Clinical correlates of vascular parkinsonism[J].Arch Neuro,1999,56(1):98-102.
  • 2Demirkiran M,Bozdemir H,Sarica Y.Vascular parkinsonism:adi-stinct,heterogeneous clinical entity[J].Acta Neurol Scand,2001,104(2):63-67.
  • 3史洪润,孙斌,蒲传强,刘军,陈宗羡,刘爱东,张国忠.血管性帕金森综合征与帕金森病对比研究[J].中国临床康复,2002,6(5):646-647. 被引量:17
  • 4Katzensch lager R,Daniel SE.The L-dopa response in vascularparkinsonism[J].J Neurol Neuro Surg Psych,2004,75(4):545-547.

二级参考文献11

  • 1魏岗之.血管性巴金森综合征的临床病理报告[J].中华内科杂志,1994,33(7):474-476. 被引量:38
  • 2户村则昭 王川芳春 加藤敏郎等.Vascular parkinsonismのcomputed tomography所见.脑と神经,1985,37:1007-1007.
  • 3MURROW RW,SCHWEIGER GO,KEPES JJ,et al. Parkinsonism due to a basal ganglia lacunar state: clinicopathologic correlation[J]. Neurology,1990,40(6):897-900.
  • 4HUGHES AJ, DANIEL SE, BLANKSON S,et al.A clinicopathologic study of 100 cases of Parkison` s disease[J].Arch Neurol, 1993,50:140-148.
  • 5YAMANOUCHI H,NAGURA H.Neurological sign and frontal white matter lesion in vascular parkinsonism[J].Stroke,1997,28(5):965-969.
  • 6WINIKATES J,JANKOVIC J.Clinical correlates of vascular parkinsonism[J].Arch Neurol, 1999,56(1):98-102.
  • 7CHANG CM, YU YL, NG HK,et al. Vascular pseudoparkinsonism[J].Acta Neurol Scand, 1992, 86: 588-592.
  • 8TOHGI H, UENO M,ABE T,et al.Concentration of monoamines and their metabolites in the cerebrospinal fluid from patients with senile dementia of the Alzheimer type and vascular dementia of Binswanger type[J].J Neural Transm [P-D sect],1992,4(1):69-77.
  • 9VAN ZAGTEN M, LODDER J, KESSELS F.Gait disorder and parkinsonian signs in patients with stroke related to small deep infarcts and white matter lesions[J].Mov Disord,1998,13(1):89-95.
  • 10赵薛旭,李作汉.血管性帕金森综合征[J].现代康复,2000,4(2):174-175. 被引量:7

共引文献16

同被引文献44

  • 1马烈,孙斌.依达拉奉治疗血管源性帕金森综合征的疗效观察[J].中国全科医学,2008,11(19):1794-1795. 被引量:19
  • 2王冰.依达拉奉治疗血管性帕金森综合征的疗效观察[J].中国实用神经疾病杂志,2007,10(9):45-46. 被引量:10
  • 3郑杰.依达拉奉联神经节苷酯治疗血管源性帕金森综合症的疗效观察[J].医学信息(下旬刊),2013,26(12):404--405.
  • 4郑杰.依达拉奉联神经节苷酯治疗血管源性帕金森综合症的疗效观察[J].医学信息:下旬刊,2013,26(12):404-405.
  • 5Oliveira A, Massano J, Rosas M J, et al. Dropped head syndrome in early-onset Parkinson disease treated with bilateral subthalamic stimulation: Clinical, imaging, EMG, and biopsy findings [ J ]. Neurol Sci, 2013,34 ( 4 ) : 593-594. DOI : 10. 1097/s10072-012- 1089-7.
  • 6Rong WT, Lu YP, Tao Q, et al. Hydroxypropyl-sulfobutyl-J3-cyclo- dextrin improves the oral bioavailability of edaravone by modula- ting drug efflux pump of enterocytes[ J]. J Pharm Sci,2014,103 (2) :730-742. DOI : 10. 1002/jps. 23807.
  • 7Sand PG. IL6-gene variation in Parkinson "s disease [ J ]. Can J Neurol Sei,2013,40(2) :268.
  • 8Bajaj NPS, Wang L, Gontu V, et al. Accuracy of subjective and objective handwriting assessment for differentiating Parkinson "s disease from tremulous subjects without evidence of dopaminergic deficits (SWEDDs) :An FP-CIT-validated study[J]. J Neurol, 2012,259 ( 11 ) : 2335-2340. DOI: 10. 1001/jamaneurol. 2014. 2704.
  • 9Scridon A, Morel E, Nonin-Babary E, et al. Increased intracardiac vascular endothelial growth factor levels in patients with paroxys- mal, but not persistent atrial fibrillation [ J ]. Europace, 2012,14 (7) :948-953. DOI : 10. 1093/europace/eur418.
  • 10Olivares Romero J, Arjona Padillo A, Barrero Herndndez FJ, et al . Utility of transcranial sonography in the diagnosis of drug-induced parkinsonism: a prospective study [J]. Eur J Neurol ,2013,20(11) : 1451-1458.

引证文献10

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部